News for Teladoc Health, Inc. (TDOC)

Teladoc Health, Inc. (NYSE:TDOC) Goldman Sachs 46th Annual Global Healthcare Conference June 11, 2025 11:30 AM ETCompany ParticipantsCharles Divita - CEO...

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Div...

Summary Teladoc Health Inc (TDOC), a global leader in virtual care, announced on June 3, 2025, that it has issued inducement awards to two new non-executive emp

Teladoc Health (TDOC) granted RSU awards for 80,000 shares to two new non-executive employees. The RSUs have a vesting schedule: one-third in the first

Teladoc (TDOC) has experienced a significant uptick in bullish options trading today, with a remarkable 19,449 call contracts changing hands. This volume is six

In recent analyst activity, Truist Securities has adjusted its price target for Teladoc Health (TDOC), a leading company in the telehealth sector. As of May 27,

Truist has revised its price target for Teladoc (TDOC), lowering it from $10 to $9 while maintaining a Hold rating on the stock. This adjustment follows an upda

PALM BEACH, Fla., May 12, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Artificial Intelligence (AI) is becoming more essential in the medical mar

We recently compiled a list of the 14 Best Growth Stocks Under $10 to Buy Right Now. In this article, we are going to take a look at where Teladoc Health, Inc. (NYSE:TDOC) stands against the other growth stocks under $10. Growth stocks refer to companies that grow their earnings and revenues at rates much above […]

Growth stocks refer to companies that grow their earnings and revenues at rates much above those of the broad market.

PR NewswireVANCOUVER, BC, May 6, 2025 USA News Group News CommentaryIssued on behalf of Avant Technologies Inc.VANCOUVER, BC, May 6, 2025 /PRNewswire/ -- H

Teladoc Health trades cheaply at 5x EV/EBITDA but lacks innovation and enrollment growth to support long-term upside. Read why TDOC stock is a buy.

\n Teladoc Health (TDOC) issues 267,328 restricted stock units as inducement awards following Uplift Health Technologies acquisition. Four Uplift Health em

**media[613279]**

Teladoc Health (TDOC) recently received an update from the renowned financial services firm, Canaccord Genuity. Analyst Richard Close has maintained a "Buy" rat

Teladoc Health (TDOC) has received an updated price target from the financial services firm Goldman Sachs. The firm's analyst, David Roman, has maintained a 'Bu

Teladoc Health (TDOC) has received an update from analyst David Grossman of Stifel. The analyst has decided to maintain the current rating of "Hold" for the sto

Canaccord has revised its price target for Teladoc (TDOC), reducing it from $14 to $12, while maintaining a Buy rating for the stock. The firm acknowledges a so

Consolidated Revenue: $629.4 million, down 3% year-over-year.Adjusted EBITDA: $58.1 million, representing a margin of 9.2%.Net Loss Per Share: $0.53, including